Vivoryon Therapeutics

About Vivoryon Therapeutics

Vivoryon Therapeutics is dedicated to creating small molecule medications by leveraging their deep understanding of pathologic pathways, with the goal of improving the lives of individuals affected by severe diseases. They aim to alter the course of these diseases by developing medicines that modulate the activity and stability of proteins altered in disease settings.

Products & Services

Varoglutamstat:An orally administered small molecule inhibitor of glutaminyl cyclases (QPCT and QPCTL), targeting enzymes involved in pyroglutamate formation, which is implicated in diseases such as inflammatory, fibrotic, neurodegenerative diseases, and cancer.

Specialties

Small molecule medications Post-translational modifications Glutaminyl cyclase inhibitors Treatment of inflammatory diseases Treatment of fibrotic diseases Treatment of neurodegenerative diseases Treatment of cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 5100000 MR: - FA: 5.1 Million FAN: 5100000	D: 2025-10-06 FD: 2025-10-06	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 25000000 MR: - FA: EUR 25 Million FAN: 25000000	D: 2023-05-26 FD: 2023-05-26	-

Private Placement Latest

2025-10-06

$5.1M

1 investor (Pro only)

Private Placement 2023-05-26

$25.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Frank Weber

Chief Executive Officer / Chief Medical Officer, Executive Director

A

Anne Doering

Chief Financial Officer, Executive Director

M

Michael Schaeffer

Chief Business Officer, Executive Director

J

Julia Neugebauer

Chief Operating Officer

E

Erich Platzer

Chairman

C

Charlotte Lohmann

Vice Chair

View 5 more team members with Pro

Unlock Full Team Directory

Recent News